IBRX
ImmunityBio Inc.
$2.67
-$0.06(-2.20%)
18
Overall
--
Value
18
Tech
--
Quality
Market Cap
$2.58B
Volume
9.03M
52W Range
$1.83 - $7.48
Target Price
$10.20
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $236.0K | $44.0K | $45.0K | $47.0K | $43.0K | $605.0K | $934.0K | $240.0K | $622.0K | $14.7M | ||
| Total Revenue | $236.0K | $44.0K | $45.0K | $47.0K | $43.0K | $605.0K | $934.0K | $240.0K | $622.0K | $14.7M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $236.0K | $44.0K | $45.0K | $47.0K | $43.0K | $605.0K | $934.0K | $240.0K | $622.0K | $14.7M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-239.1M | $-124.5M | $-99.2M | $-98.4M | $67.8M | $221.5M | $331.2M | $350.9M | $362.9M | $358.9M | ||
| Research & Development | $11.4M | $29.2M | $42.0M | $55.7M | $49.8M | $139.5M | $196.0M | $248.1M | $232.4M | $190.1M | ||
| Research Expense | $11.4M | $29.2M | $42.0M | $55.7M | $49.8M | $139.5M | $196.0M | $248.1M | $232.4M | $190.1M | ||
| Selling, General & Administrative | $227.7M | $95.4M | $57.1M | $42.7M | $18.1M | $71.3M | $135.3M | $102.7M | $129.6M | $168.8M | ||
| Selling & Marketing Expenses | $227.7M | $95.4M | $57.1M | $42.7M | -- | -- | -- | -- | -- | -- | ||
| General & Administrative Expenses | $-1.5M | $-2.7M | $-2.7M | $-2.8M | $18.1M | $71.3M | $135.3M | $102.7M | $129.6M | $168.8M | ||
| Salaries & Wages | $-211.2M | $-73.9M | $-37.0M | $-23.4M | -- | -- | -- | $40.2M | $49.2M | $34.4M | ||
| Depreciation & Amortization | $-100.0K | $-1.0M | $-3.3M | $-7.3M | $8.4M | $12.7M | $14.2M | $16.3M | $16.5M | $15.5M | ||
| Depreciation & Amortization | $-100.0K | $-1.0M | $-3.3M | $-7.3M | $8.4M | $12.7M | $14.2M | $16.3M | $16.5M | $15.5M | ||
| Amortization | $-1.3M | $-2.6M | $-2.3M | $-2.3M | $600.0K | -- | $1.4M | $20.0M | $2.0M | $2.0M | ||
| Other Operating Expenses | $-239.1M | $-124.5M | $-99.2M | $-98.4M | $-3.7M | $-4.8M | $-536.0K | $-1.7M | $-19.0M | $-1.3M | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-238.9M | $-124.5M | $-99.1M | $-98.4M | $-67.8M | $-220.9M | $-330.3M | $-351.3M | $-362.3M | $-344.2M | ||
| EBITDA | $-235.7M | $-115.5M | $-89.1M | $-86.3M | $-56.9M | $-204.2M | $-320.8M | $-313.3M | $-222.5M | $-142.2M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | -- | $66.0K | $618.0K | $433.0K | $19.0K | $9.1M | $14.8M | $63.5M | $128.9M | $114.7M | ||
| Intinc | $312.0K | $5.2M | $4.2M | $2.3M | $1.6M | $1.7M | $836.0K | $2.7M | $863.0K | $2.4M | ||
| Net Non-Operating Interest Income/Expense | $3.0M | $3.0M | $2.0M | $1.4M | $-19.0K | $-9.1M | $-14.8M | $60.8M | $-128.1M | $-112.3M | ||
| Gain on Sale of Securities | $2.5M | $190.0K | $52.0K | $3.0K | $1.6M | $2.4M | $-4.1M | $-3.1M | $1.1M | $21.5M | ||
| Other Income/Expense | $1.3M | $-88.0K | $-157.0K | $-236.0K | $-1.9M | $6.8M | $4.7M | $-5.9M | $57.1M | $-41.4M | ||
| Other Special Charges | $-1.3M | $88.0K | $157.0K | $236.0K | $298.0K | $1.5M | $193.0K | $12.7M | $-49.8M | $19.9M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | -- | -- | -- | $-1.0M | -- | -- | ||
| Special Income Charges | -- | -- | -- | -- | $12.0M | -- | -- | $1.0M | -- | -- | ||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | $10.7M | -- | $681.0K | $886.0K | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-237.2M | $-121.3M | $-96.3M | $-96.3M | $-65.9M | $-217.0M | $-337.1M | $-353.8M | $-289.6M | $-188.1M | ||
| Pre-Tax Income | $-237.2M | $-121.4M | $-96.9M | $-96.7M | $-65.9M | $-226.0M | $-349.8M | $-417.3M | $-583.9M | $-413.6M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $-301.0K | $-572.0K | $-493.0K | $-503.0K | $-97.0K | $-1.8M | $9.0K | $34.0K | $-40.0K | -- | ||
| NET INCOME | ||||||||||||
| Net Income | $-236.9M | $-120.8M | $-96.4M | $-96.2M | $-65.8M | $-221.9M | $-346.8M | $-416.6M | $-583.2M | $-413.6M | ||
| Net Income (Continuing Operations) | $-236.9M | $-120.8M | $-96.4M | $-96.2M | $-65.8M | $-221.9M | $-346.8M | $-417.3M | $-418.5M | $-413.6M | ||
| Net Income (Discontinued Operations) | $-236.9M | $-120.8M | $-96.4M | $-96.2M | $-65.8M | $-221.9M | $-346.8M | $-416.6M | $-583.2M | $-413.6M | ||
| Net Income (Common Stockholders) | $-236.9M | $-120.8M | $-96.4M | $-96.2M | $-65.8M | $-221.9M | $-346.8M | $-416.6M | $-417.8M | $-413.6M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-409.5M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-239.1M | $-124.5M | $-99.2M | $-98.4M | $67.8M | $221.5M | $331.2M | $350.9M | $362.9M | $358.9M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $71.5M | $82.0M | $80.6M | $79.1M | $94.2M | $103.6M | $389.2M | $399.9M | $508.6M | $697.3M | ||
| Average Shares Outstanding (Diluted) | $71.6M | $82.2M | $80.4M | $78.9M | $94.2M | $103.6M | $389.2M | $399.9M | $508.6M | $700.4M | ||
| Shares Outstanding | $81.9M | $82.3M | $79.0M | $79.1M | $98.5M | $109.3M | $397.9M | $435.8M | $674.0M | $853.4M | ||
| Basic EPS | -- | -- | -- | -- | $-0.70 | $-0.89 | $-0.89 | $-1.04 | $-1.15 | $-0.59 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | $-0.70 | $-0.89 | $-0.89 | $-1.04 | $-1.15 | $-0.59 | ||
| Diluted EPS | $-3.31 | $-1.47 | $-1.2 | $-1.22 | $-0.70 | $-0.89 | $-0.89 | $-1.04 | $-1.15 | $-0.62 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | -- | $-0.89 | $-1.04 | $-1.15 | $-0.62 | ||
| OTHER METRICS | ||||||||||||
| Commission Expenses | -- | $-36.0K | $-100.0K | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings from equity interest | -- | -- | -- | -- | -- | -- | $-803.0K | $-12.1M | $-7.5M | -- | ||
| Earnings From Equity Interest Net Of Tax | -- | -- | -- | -- | -- | -- | $-803.0K | $-12.1M | $-7.5M | -- | ||
| Interest Expense Operating | -- | -- | -- | -- | -- | -- | $-2.1M | $-35.4M | -- | -- | ||
| Minority Interests | -- | -- | -- | -- | -- | $2.3M | $3.1M | $753.0K | $656.0K | $81.0K | ||
| Non Recurring Operation Expense | -- | -- | -- | -- | $-12.0M | -- | -- | -- | -- | -- | ||
| Other Gand A | $-1.5M | $-2.7M | $-2.7M | $-2.8M | $18.1M | $71.3M | $135.3M | $102.7M | $129.6M | $168.8M | ||
| Rent And Landing Fees | $-1.5M | $-2.7M | $-2.7M | $-2.8M | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $227.7M | $95.4M | $57.1M | $42.7M | -- | -- | -- | -- | -- | -- | ||
| Restruct | -- | -- | -- | -- | -- | -- | -- | $-1.0M | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IBRX | $2.67 | -2.2% | 9.03M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |